期刊文献+

甲状腺肿瘤3号染色体短臂杂合性缺失的研究

Loss of heterozygosity on chromosome 3p in thyroid tumors
原文传递
导出
摘要 目的 探讨甲状腺肿瘤中3号染色体短臂(3p)杂合性缺失(LOH)状态及其临床意义。方法 收集74例甲状腺肿瘤标本,包括20例甲状腺腺瘤(FA)、24例滤泡性甲状腺癌(FTC)和30例乳头状甲状腺癌(PTC)。通过PCR扩增和银染分析其3p上11个微卫星位点的杂合性缺失状态。结果 FIE的LOH频率达到71%(17/24),PTC中30%(9/30),FA中10%(2/20)。FTC的3p LOH频率显著高于FA和PTC(P〈0.01)。FTC中存在两个最小共同缺失区,分别位于3p26-pter和3p14.2-3p22。PTC上存在一个最小共同缺失区,位于3p25.2-26.1。结论 FTC的3p LOH频率显著高于FA和PTC。3p的3个最小缺失区上可能存在着与FTC和PTC发生发展相关的肿瘤抑制基因。 Objective To study the loss of heterozygosity (LOH) on chromosome 3p in thyroid tumors. Methods LOH at 11 microsatellite loci was analyzed in 74 cases of thyroid tumors ( including 20 follicular adenomas, 24 follicular thyroid carcinomas and 30 papillary thyroid carcinomas) by polymerase chain reaction and silver stain. Results LOH on chromosome 3p was detected in 71% of follicular thyroid carcinoma ( 17/24), 30% of the papillary thyroid carcinoma (9/30) and 10% of the follicular adenoma (2/20) case. Two minimal common deleted regions (CDR) (3p26-pter and 3p14.2-3p22) involving significant sites of LOH has identified in follicular thyroid carcinoma. There was also one CDR ( 3p25. 2- 26. 1 ) in papillary thyroid carcinoma. Condnsions LOH is more frequently identified in follicular thyroid carcinoma than in papillary thyroid carcinoma and follicular adenoma. The 3 CDR on chromosome 3p may harbor tumor suppressor genes involved in the pathogenesis of follicular thyroid carcinoma and papillary thyroid carcinoma.
出处 《中华病理学杂志》 CAS CSCD 北大核心 2008年第5期305-308,共4页 Chinese Journal of Pathology
基金 浙江省医药卫生科学研究基金[2007(B)218]
关键词 甲状腺肿瘤 染色体 3对 杂合子丢失 Thyroid carcinoma Chromosomes,human,pair 3 Loss ofheterozygosity
  • 相关文献

参考文献8

  • 1Pavelic K, Dedivitis RA, Kapitanovic S, el al. Molecular genetic alterations of FHIT and p53 genes in benign and malignant thyroid gland lesions. Mutat Res, 2006, 599(1-2) :45-57.
  • 2Sarquis MS, Weber F, Shen L, et al. High frequency of loss of heterozygosity in imprinted, compared with nonimprinted, genomic regions in follicular thyroid carcinomas and atypical adenomas. J Clin Endocrinol Metab, 2006, 91 (1) : 262-269.
  • 3Wozniak A, Wiench M, Olejniczak A, et al. Loss of heterozygosity in 73 human thyroid tumors. Neuro Endocrinol Lett, 2005,26(5) :521-525.
  • 4Rodrigues-Serpa A, Catarino A, Soares J. Loss of heterozygosity in follicular and papillary thyroid carcinomas. Cancer Genet Cytogenet, 2003, 141 ( 1 ) : 26-31.
  • 5Chmara M, Wozniak A, Ochman K, et al. Loss of heterozygosity at chromosomes 3p and 17p in primary non-small cell lung cancer.Anticancer Res, 2004, 24(6) : 4259-4263.
  • 6李立,安倩,冯晓莉,张建军,黄进丰,刘乐尧,程书钧,高燕宁.肺癌组织3号染色体短臂上抑癌基因异常改变的初步分析[J].中华医学杂志,2001,81(7):399-401. 被引量:14
  • 7汤绚丽,姚根有,杨泽然,李世兰,陈丽荣.乳腺癌及癌前病变3号染色体短臂杂合性缺失的研究[J].中华外科杂志,2006,44(19):1314-1317. 被引量:6
  • 8Grebe SK, Mciver B, Hay ID, et al. Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma. J Clin Endocrinol Metab, 1997, 82(11 ) :3684-3691.

二级参考文献17

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部